Success Stories: Our Team Successfully Obtained NIW and EB1A Approval for a Chinese Associate Professor in the Field of Pathogenic Biology

Client’s Testimonial:

“I really appreciate your great help in the process of my case. I think my EB1A case will also be smooth like my NIW case (which was approved in only 1 month with no PP). Thank you so much again.”

On April 13^th, 2023 and February 21^st, 2024, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) Approval for an Associate Professor in the Field of Pathogenic Biology (Approval Notice).

General Field: Pathogenic Biology

Position at the Time of Case Filing: Associate Professor

Country of Origin: China

Country of Residence at the Time of Filing: China

Approval Notice Date: April 13^th, 2023 (NIW) and February 21^st, 2024 (EB1A)

Processing Time: 1 month (NIW) and 10 months (EB1A)

Case Summary:

Our client, an associate professor in the field of pathogenic biology, holds a Ph.D. in pathogenic organisms. She first approached the North America Immigration Law Group for her NIW (National Interest Waiver) petition. She mailed us her credentials, which our knowledgeable attorneys examined thoroughly, and customized her NIW petition to meet the specific requirements.

We began by highlighting her remarkable work that has been fundamental to studying the interaction between bacteria and host. She has made significant original contributions to the field of pathogenic biology, addressing some of the nation’s and the world’s most pressing issues, including severe bacterial infections.

In March 2023, we submitted her NIW petition to USCIS, which was approved in just one month without the need for a premium processing upgrade, a great achievement.

Impressed by our efforts on her NIW petition, a month after its approval, our client hired us again to file an I-140 EB1A (Alien of Extraordinary Ability) visa petition. Our client’s exceptional scientific background made her an ideal candidate for this visa, and we discussed her 35 peer-reviewed scientific articles published in high-impact journals in the field, earning a combined 1,068 citations. These publications demonstrate the impact she has had on her peers and colleagues in the field.

Also, she has completed 30 peer reviews, demonstrating her active and genuine participation in evaluating the work of other pathogenic biology specialists.

Moreover, our client has received recognition and funding support from various major organizations, including the National Natural Science Foundation of China (NSFC) and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), which serves as evidence that her work is important to the international pathogenic biology community.

When we submitted documentation of our client’s research and letters of recommendation from renowned professionals in her field, attesting to her exceptional research abilities, she received her EB1A approval without any RFE issuance.

Experts agree that her continued participation is critical to the overall success of bacterial infection treatment in the field of pathogenic biology. Therefore, her past and current achievements suggest that she will continue to provide substantial benefits to the United States. We are delighted to have provided USCIS with all the relevant information regarding our client’s research and to receive two wonderful approval stories (NIW and EB1A) in a row. We wish our client all the best in her future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.